文献速递生殖医学

辅助生殖与COVID-19大流行中的血栓栓塞风险

Assisted reproduction and thromboembolic risk in the COVID-19 pandemic.
PubMed 文献 · Reprod Biomed Online · 2020-06-25

本文为评论性文章,分析病毒感染相关血栓风险与辅助生殖治疗血栓风险之间的共存要素。基于病毒感染和卵巢刺激的已知病理生理机制,作者提出:应避免过度刺激,高反应患者和/或COVID-19感染者必须使用促性腺激素释放激素激动剂扳机并行周期分段,预防性使用低分子肝素,冻融胚胎移植内膜准备采用经皮途径。

要点

  • 应避免任何过度刺激风险。
  • 高反应患者和/或COVID-19感染者必须使用促性腺激素释放激素激动剂扳机,两种情况下周期均应分段。
  • 作者提出预防性低分子肝素不仅用于已取卵者,也用于决定取消周期者。

核心结论

  • 在COVID-19大流行背景下,病毒感染相关血栓风险与辅助生殖治疗血栓风险存在共同病理生理要素,需加以考虑。

研究设计与样本

  • 本文为评论性文章,分析病毒感染期间描述的血栓风险与辅助生殖治疗背景下报告的血栓风险之间的共存方面。

主要发现

  • COVID-19大流行使许多国家死亡率显著增加,感染病例数在全球呈指数增长。
  • 这些患者预后不良的主要决定因素之一是凝血病的发生。
  • 辅助生殖技术操作已知具有血栓栓塞并发症风险。
  • 基于病毒感染和卵巢刺激的已知病理生理方面,存在值得考虑的共有要素。

关键数值与推荐

  • 在当前背景下,应避免任何过度刺激风险。
  • 高反应患者和/或COVID-19感染者必须使用促性腺激素释放激素激动剂扳机。
  • 上述两种情况下,周期均应分段。
  • 作者提出预防性低分子肝素不仅用于已行取卵者,也用于已决定取消周期者。
  • 冻融胚胎移植的内膜准备应采用经皮途径,以尽量减少与口服途径相关的较高血栓风险。

临床怎么用

  • 作者提出在高反应患者和/或COVID-19感染者中使用促性腺激素释放激素激动剂扳机并分段周期。
  • 作者提出预防性低分子肝素用于已取卵者及决定取消周期者。
  • 作者建议冻融胚胎移植内膜准备采用经皮途径。
  • 原文未报告具体用药方案、剂量或监测阈值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The COVID-19 pandemic has significantly increased mortality in many countries, with the number of infected cases increasing exponentially worldwide. One of the main determining factors of the poor prognosis in these patients is the development of coagulopathy. Moreover, it is well known that assisted reproductive technology procedures confer a risk of thromboembolic complications. This commentary analyses specific aspects coexisting between the thrombotic risk described during virus infection and that reported in the context of assisted reproduction treatments. Based on known pathophysiological aspects of virus infection and of ovarian stimulation, there are common elements that deserve to be taken into account. In the present context, any risk of hyperstimulation should be avoided. Gonadotrophin-releasing hormone agonist triggering should be mandatory in high-responder patients and/or those with COVID-19 infection. In both cases, the cycle should be segmented. A proposal is made for the use of prophylactic low molecular weight heparin not only in those cases in which oocyte retrieval has been performed, but also in those in which cancellation has been decided. In addition, endometrial preparation for frozen-thawed embryo transfers should use the transdermal route in order to minimize the higher thrombotic risk associated with the oral route.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Fabregues F, Peñarrubia J. Assisted reproduction and thromboembolic risk in the COVID-19 pandemic. Reprod Biomed Online. 2020. PMID: 32660814. doi:10.1016/j.rbmo.2020.06.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。